AI Article Synopsis

  • The study finds that left ventricular thrombus (LVT) occurs in 7.1% of patients after anterior acute ST-segment elevation myocardial infarction (ant-AMI) and is linked to higher rates of major adverse cardio-cerebrovascular events (MACCE) within a year.
  • Patients with LVT experienced significantly more MACCE (21.7%) compared to those without LVT (10.3%), and LVT was identified as an independent risk factor even after adjusting for other variables.
  • The findings suggest that maintaining an international normalized ratio (INR) of 2 or higher in patients with LVT may lower the risk of MACCE and enhance the likelihood of thrombus disappearance.

Article Abstract

Background: The incidence of left ventricular thrombus (LVT) is 4% to 15% in patients with anterior acute ST-segment elevation myocardial infarction (ant-AMI) in the era of primary percutaneous coronary intervention (PPCI). And patients with LVT have higher in-hospital mortality.

Hypothesis: There is a relationship between LVT formation and 1-year major adverse cardio-cerebrovascular events (MACCE) in patients with ant-AMI treated by PPCI.

Methods: Our study population included 1488 consecutive patients with ant-AMI. The primary endpoint was the incidence of MACCE within 1 year after AMI. The secondary endpoint was the thrombosis disappearance.

Results: A total of 106 (7.1%) patients were diagnosed with LVT and 1382 (92.9%) patients without LVT. Patients with LVT had a higher incidence of MACCE than in patients without LVT (21.7%vs10.3%; P < 0.001). Univariate analysis showed LVT was associated with an increase in MACCE risk (odds ratio [OR] = 2.40; 95% confidence interval [CI] [1.37-4.21]; P < 0.001). When examining MACCE components individually, LVT was only associated with the incidence of congestive heart failure (OR = 2.41; 95% CI [1.29-4.58]; P = 0.001). After adjustment for principal confounders, LVT remained an independent risk factor for MACCE (HR = 2.28; 95% CI [1.12-6.38]; P = 0.020). Other independent predictors include 24-hour LVEF, creatine kinase peak value, and age. Further analysis found patients with LVT in international normalized ratio (INR) ≥ 2 group had lower MACCE risk and higher thrombus disappearance than in INR < 2 group (13.5%vs29.6%; P = 0.044; 90.4%vs74.1%; P = 0.029).

Conclusion: For patients with ant-AMI treated by PPCI, LVT is an independent predictor of 1-year MACCE events. Treatment with vitamin K antagonist in the therapeutic range (INR ≥ 2) has the potential to reduce MACCE risk and promote disappearance of thrombus.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436520PMC
http://dx.doi.org/10.1002/clc.23106DOI Listing

Publication Analysis

Top Keywords

patients lvt
20
lvt
12
patients ant-ami
12
macce risk
12
patients
11
macce
9
left ventricular
8
ventricular thrombus
8
myocardial infarction
8
primary percutaneous
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!